Skip to main content

Table 2 Clinical results

From: Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device

 

All patients

N = 189

eGFR≥45

N = 116

eGFR< 45

N = 73

p

Follow-up duration, years

310

188

122

 

Cerebrovascular events, n (n/100py)

3 (1.0)

0

3 (2.5)

0.09

 • Stroke, n (n/100py)

2

0

2 (1.6)

ns

 • TIA, n (n/100py)

1

0

1 (0.8)

ns

Bleeding complications, n (n/100py)

5 (1.6)

0

5 (4.1)

0.06

 • Intracranial bleeding

0

0

0

 

 • Gastrointestinal bleeding

1 (0.3)

0

1 (0.8)

ns

 • Other bleeding

4 (1.3)

0

4 (3.3)

ns

All-cause death, n (n/100py)

8 (2.6)

2 (1.1)

6 (4.9)

ns

 • Cardiovascular death, n (n/100py)

6 (1.9)

2 (1.1)

4 (3.3)

ns

Periprocedural complications

 • Pericardial effusion, n (%)

0

0

0

 

 • DRT, n (%)

12 (6.5)

6 (3.2)

6 (8.2)

ns

 • Other peri-procedural complications, n (%)

4 (2.1)

2 (1.7)

2 (2.7)

ns

  1. 100py = one hundred patient years; TIA = transitory ischemic attack; DRT = device related thrombus